SCHEMBL2364941

SCHEMBL2364941

CCOc1ccc(C(CC(=O)O)NC(=O)c2cc(OCC(C)(O)C(C)C)n(-c3ccccc3F)n2)cc1

nearest known ligand 0.64

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CTSA P10619 17/20 0.64
▸ CYP3A4 P08684 3/20 0.64
▸ MME P08473 2/20 0.56
▸ PTGS2 P35354 2/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2364942 1.00 CTSA (0.64) CTSACYP3A4MMEPTGS2NPSR1
SCHEMBL2364991 1.00 CTSA (0.64) CTSACYP3A4MMEPTGS2NPSR1
SCHEMBL2365150 1.00 CTSA (0.64) CTSACYP3A4MMEPTGS2NPSR1
SCHEMBL2364857 0.93 CTSA (0.63) CTSACYP3A4MMEPTGS2
SCHEMBL2364622 0.93 CTSA (0.63) CTSACYP3A4MMEPTGS2
SCHEMBL15639920 0.93 CTSA (0.63) CTSACYP3A4MMEPTGS2
SCHEMBL2364621 0.93 CTSA (0.63) CTSACYP3A4MMEPTGS2
SCHEMBL14696355 0.93 CTSA (0.59) CTSACYP3A4MMEPTGS2
SCHEMBL14696628 0.93 CTSA (0.59) CTSACYP3A4MMEPTGS2
SCHEMBL14696357 0.93 CTSA (0.59) CTSACYP3A4MMEPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014053533-A1 USE OF SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AS PHARMACEUTICALS FOR PREVENTION/TREATMENT OF ATRIAL FIBRILLATION SANOFI (FR) 2014-04-10 — — WO disclosed
EP-2528902-A1 OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2012-12-05 — — EP disclosed
WO-2011092187-A1 OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2011-08-04 — — WO disclosed
Send feedback